acetaminophen
- Product NDC
- 69842-484
- 11-digit product format
- 698420484
- Labeler code
- 69842
- Product ID
- 69842-484_5a9381a8-3dae-4260-8466-cabec7e0274f
- Type
- HUMAN OTC DRUG
- Nonproprietary name
- Acetaminophen
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- CVS Pharmacy
- Application
- M013
- Marketing category
- OTC MONOGRAPH DRUG
- Marketing start
- 2018-06-12
- Substance
- ACETAMINOPHEN
- Active strength
- 500 mg/1
- NDC exclude flag
- No
- Listing certified through
- 2027-12-31
- Current FDA listing
- Yes
NDC auxiliary status#
These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.
| Dataset | Scope | Product NDC | Package NDC | Code | Status | Reporting period | Source date |
|---|---|---|---|---|---|---|---|
| excluded package | package | 69842-484 | 69842-484-47 | D | Discontinued by firm | 2026-10-16 | |
| excluded package | package | 69842-484 | 69842-484-87 | D | Discontinued by firm | 2026-10-16 | |
| excluded package | package | 69842-484 | 69842-484-90 | D | Discontinued by firm | 2026-10-16 | |
| excluded package | package | 69842-484 | 69842-484-93 | D | Discontinued by firm | 2026-10-16 |
Observed NDC auxiliary status history#
This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
| Captured / source date | Package NDC | Snapshot | Source SHA-256 |
|---|---|---|---|
| 2025-12-14 17:58 UTC · source 2025-12-05 | 69842-484-47 | d630ba8d3edf… | 732f749b63fb… |
| 2025-12-14 17:58 UTC · source 2025-12-05 | 69842-484-90 | d630ba8d3edf… | 732f749b63fb… |
| 2025-12-14 17:58 UTC · source 2025-12-05 | 69842-484-93 | d630ba8d3edf… | 732f749b63fb… |
| 2025-12-14 17:58 UTC · source 2025-12-05 | 69842-484-87 | d630ba8d3edf… | 732f749b63fb… |
| 2025-08-27 00:01 UTC · source 2025-08-26 | 69842-484-87 | f5e01cc5f278… | a2eaf40c39c3… |
| 2025-08-27 00:01 UTC · source 2025-08-26 | 69842-484-90 | f5e01cc5f278… | a2eaf40c39c3… |
| 2025-08-27 00:01 UTC · source 2025-08-26 | 69842-484-47 | f5e01cc5f278… | a2eaf40c39c3… |
| 2025-08-27 00:01 UTC · source 2025-08-26 | 69842-484-93 | f5e01cc5f278… | a2eaf40c39c3… |
| 2025-04-01 02:39 UTC · source 2025-03-31 | 69842-484-87 | 2ef7874e63bc… | 57b86245f4fa… |
| 2025-04-01 02:39 UTC · source 2025-03-31 | 69842-484-90 | 2ef7874e63bc… | 57b86245f4fa… |
| 2025-04-01 02:39 UTC · source 2025-03-31 | 69842-484-47 | 2ef7874e63bc… | 57b86245f4fa… |
| 2025-04-01 02:39 UTC · source 2025-03-31 | 69842-484-93 | 2ef7874e63bc… | 57b86245f4fa… |
| 2025-03-28 20:22 UTC · source 2025-03-28 | 69842-484-87 | a1b67e2a42f9… | c4cf2c586c0d… |
| 2025-03-28 20:22 UTC · source 2025-03-28 | 69842-484-90 | a1b67e2a42f9… | c4cf2c586c0d… |
| 2025-03-28 20:22 UTC · source 2025-03-28 | 69842-484-47 | a1b67e2a42f9… | c4cf2c586c0d… |
| 2025-03-28 20:22 UTC · source 2025-03-28 | 69842-484-93 | a1b67e2a42f9… | c4cf2c586c0d… |
| 2025-03-22 03:12 UTC · source 2025-03-21 | 69842-484-87 | cfe11265f3b6… | 090c488252e2… |
| 2025-03-22 03:12 UTC · source 2025-03-21 | 69842-484-90 | cfe11265f3b6… | 090c488252e2… |
| 2025-03-22 03:12 UTC · source 2025-03-21 | 69842-484-47 | cfe11265f3b6… | 090c488252e2… |
| 2025-03-22 03:12 UTC · source 2025-03-21 | 69842-484-93 | cfe11265f3b6… | 090c488252e2… |
| 2025-03-10 12:48 UTC · source 2025-03-10 | 69842-484-87 | cdf11ea48f46… | ba0047e9e063… |
| 2025-03-10 12:48 UTC · source 2025-03-10 | 69842-484-90 | cdf11ea48f46… | ba0047e9e063… |
| 2025-03-10 12:48 UTC · source 2025-03-10 | 69842-484-47 | cdf11ea48f46… | ba0047e9e063… |
| 2025-03-10 12:48 UTC · source 2025-03-10 | 69842-484-93 | cdf11ea48f46… | ba0047e9e063… |
| 2025-02-02 03:52 UTC · source 2025-01-31 | 69842-484-87 | 302b2466d912… | e7b80fea0513… |
| 2025-02-02 03:52 UTC · source 2025-01-31 | 69842-484-90 | 302b2466d912… | e7b80fea0513… |
| 2025-02-02 03:52 UTC · source 2025-01-31 | 69842-484-47 | 302b2466d912… | e7b80fea0513… |
| 2025-02-02 03:52 UTC · source 2025-01-31 | 69842-484-93 | 302b2466d912… | e7b80fea0513… |
| 2025-01-20 13:05 UTC · source 2025-01-20 | 69842-484-87 | ed331223b511… | 672a5bd82f5f… |
| 2025-01-20 13:05 UTC · source 2025-01-20 | 69842-484-90 | ed331223b511… | 672a5bd82f5f… |
| 2025-01-20 13:05 UTC · source 2025-01-20 | 69842-484-47 | ed331223b511… | 672a5bd82f5f… |
| 2025-01-20 13:05 UTC · source 2025-01-20 | 69842-484-93 | ed331223b511… | 672a5bd82f5f… |
| 2025-01-11 03:41 UTC · source 2025-01-10 | 69842-484-87 | 0efc9e666f02… | f202fb6c5f17… |
| 2025-01-11 03:41 UTC · source 2025-01-10 | 69842-484-90 | 0efc9e666f02… | f202fb6c5f17… |
| 2025-01-11 03:41 UTC · source 2025-01-10 | 69842-484-47 | 0efc9e666f02… | f202fb6c5f17… |
| 2025-01-11 03:41 UTC · source 2025-01-10 | 69842-484-93 | 0efc9e666f02… | f202fb6c5f17… |
| 2024-11-09 02:27 UTC · source 2024-11-08 | 69842-484-87 | ad56d346431e… | cc804d4bbf1e… |
| 2024-11-09 02:27 UTC · source 2024-11-08 | 69842-484-90 | ad56d346431e… | cc804d4bbf1e… |
| 2024-11-09 02:27 UTC · source 2024-11-08 | 69842-484-47 | ad56d346431e… | cc804d4bbf1e… |
| 2024-11-09 02:27 UTC · source 2024-11-08 | 69842-484-93 | ad56d346431e… | cc804d4bbf1e… |
| 2024-10-04 04:10 UTC · source 2024-10-03 | 69842-484-87 | 367a005e9d99… | 383a685ebd0f… |
| 2024-10-04 04:10 UTC · source 2024-10-03 | 69842-484-90 | 367a005e9d99… | 383a685ebd0f… |
| 2024-10-04 04:10 UTC · source 2024-10-03 | 69842-484-47 | 367a005e9d99… | 383a685ebd0f… |
| 2024-10-04 04:10 UTC · source 2024-10-03 | 69842-484-93 | 367a005e9d99… | 383a685ebd0f… |
| 2024-07-10 04:00 UTC · source 2024-07-09 | 69842-484-47 | 557ba5c1ecfa… | 9c80585c8c6e… |
| 2024-07-10 04:00 UTC · source 2024-07-09 | 69842-484-93 | 557ba5c1ecfa… | 9c80585c8c6e… |
| 2024-07-10 04:00 UTC · source 2024-07-09 | 69842-484-87 | 557ba5c1ecfa… | 9c80585c8c6e… |
| 2024-07-10 04:00 UTC · source 2024-07-09 | 69842-484-90 | 557ba5c1ecfa… | 9c80585c8c6e… |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- acetaminophen
- Listing expiration
- 2027-12-31
Active Ingredients#
| Ingredient | Strength |
|---|---|
| ACETAMINOPHEN | 500 mg/1 |
Harmonized UNII identifiers#
| Identifier | FDA.report destination |
|---|---|
| 362O9ITL9D | Internal UNII lookup |
Harmonized RxCUI identifiers#
| Identifier | FDA.report destination |
|---|---|
| 198440 | Internal RxNorm lookup |
Harmonized SPL set identifiers#
| Identifier | FDA.report destination |
|---|---|
| fc2d4367-8884-4b76-aa3e-8c35be1ace49 | Available on FDA.report |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 69842-484-47 | acetaminophen | 1 in 1 CARTON | TABLET | 1 | 6 | |
| 69842-484-47 | acetaminophen | 150 in 1 BOTTLE | TABLET | 150 | 6 | |
| 69842-484-62 | acetaminophen | 1 in 1 CARTON | TABLET | 1 | 6 | |
| 69842-484-62 | acetaminophen | 24 in 1 BOTTLE | TABLET | 24 | 6 | |
| 69842-484-71 | acetaminophen | 50 in 1 BOTTLE | TABLET | 50 | 6 | |
| 69842-484-71 | acetaminophen | 1 in 1 CARTON | TABLET | 1 | 6 | |
| 69842-484-78 | acetaminophen | 1 in 1 CARTON | TABLET | 1 | 6 | |
| 69842-484-78 | acetaminophen | 100 in 1 BOTTLE | TABLET | 100 | 6 | |
| 69842-484-83 | acetaminophen | 1 in 1 CARTON | TABLET | 1 | 6 | |
| 69842-484-83 | acetaminophen | 225 in 1 BOTTLE | TABLET | 225 | 6 | |
| 69842-484-87 | acetaminophen | 150 in 1 BOTTLE | TABLET | 150 | 6 | |
| 69842-484-87 | acetaminophen | 2 in 1 CARTON | TABLET | 2 | 6 | |
| 69842-484-90 | acetaminophen | 500 in 1 BOTTLE | TABLET | 500 | 6 | |
| 69842-484-93 | acetaminophen | 1000 in 1 BOTTLE | TABLET | 1000 | 6 |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 69842-484-62 | EA - Each | 69842-484 | 144202f0-c28c-4c01-9a62-8c0d8fa6dbfc | 1 | 2020-02-13 |
| 69842-484-71 | EA - Each | 69842-484 | 6acb8903-d469-4d15-a1db-80a76d63b15a | 1 | 2020-02-13 |
| 69842-484-90 | EA - Each | 69842-484 | 4c3292b2-3b99-4815-9fa5-e579d9b6cf80 | 1 | 2019-06-19 |
| 69842-484-93 | EA - Each | 69842-484 | 001bb4ea-638c-40c1-b701-6c673e4f1415 | 1 | 2020-02-13 |
DailyMed Dashboard NDC Coverage#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Goodys Cool Orange Headache | ACETAMINOPHEN AND ASPIRIN AND CAFFEINE | Medtech Products Inc. | 31212c97-9975-427e-bc3d-f7125f30299a | 2025-10-23 | Warnings | M013 |
| BC Arthritis | ASPIRIN AND CAFFEINE | Medtech Products Inc. | 3a85be2d-6548-4de5-8109-60e1ca2bfca3 | 2025-10-23 | Warnings | M013 |
| Goodys Extra Strength | ACETAMINOPHEN, ASPIRIN, AND CAFFEINE | Medtech Products Inc. | d4325b17-23bc-44ac-868d-bb0886853a73 | 2025-10-23 | Warnings | M013 |
| BC | ASPIRIN AND CAFFEINE | Medtech Products Inc. | 226173d4-b6d5-4fe6-b24e-1cc5d1b31c88 | 2025-10-23 | Warnings | M013 |
| BC MAX | ASPIRIN, ACETAMINOPHEN, CAFFEINE | Medtech Products Inc. | 1e2a07ab-23e6-49b4-a676-212dc6880f14 | 2025-10-23 | Warnings | M013 |
| Ecotrin Regular Strength | ASPIRIN | Medtech Products Inc. | 36cb530b-25b2-4f62-a25d-aa04360815a8 | 2025-10-23 | Warnings | M013 |
| Childrens Pain and Fever | ACETAMINOPHEN | TOPCO ASSOCIATES LLC | bbc367cc-6c79-498e-8fca-1347e6ea1a8c | 2025-10-22 | Warnings | M013 |
| Acetaminophen | ACETAMINOPHEN | Rugby Laboratories | b16ed4ef-689c-4df2-ab6c-207aa8b9925d | 2025-10-22 | Warnings | M013 |
| Tension Headache Relief | ACETAMINOPHEN, CAFFEINE | TIME CAP LABS INC | 05364eb4-07a1-a4d9-e063-6294a90a47e5 | 2025-10-21 | Warnings | M013 |
| Acetaminophen, Aspirin, Caffeine | ACETAMINOPHEN, ASPIRIN, CAFFEINE | CVS Pharmacy, Inc. | 6deb854f-863e-24ad-e053-2991aa0afb17 | 2025-10-21 | Warnings | M013 |
| BackAid | ACETAMINOPHEN, CAFFEINE | Kobayashi Healthcare International, Inc. | 25db6bb5-96b6-4be1-e063-6294a90a2300 | 2025-10-21 | Warnings | M013 |
| M-PAP | ACETAMINOPHEN | Method Pharmaceuticals, LLC | 1539dc44-15a0-153b-e063-6294a90a9d45 | 2025-10-21 | Warnings | M013 |
| M-PAP | ACETAMINOPHEN | Method Pharmaceuticals, LLC | 3d1bb61c-15db-4eba-aba9-cfbcbc7b30e0 | 2025-10-21 | Warnings | M013 |
| Walgreens Antacid Pain Relief Extra Strength | ASPIRIN, CITRIC ACID, SODIUM BICARBONATE | Walgreens | b60df498-07db-500b-e053-2a95a90aff6a | 2025-10-17 | Warnings | M013 |
| Equate Effervescent Antacid and Pain Relief | ASPIRIN, CITRIC ACID, SODIUM BICARBONATE | Walmart | 6271b34b-55a0-40a8-e053-2a91aa0acb22 | 2025-10-17 | Warnings, Adverse reactions | M013 |
| Xesso Neo | BENZOCAINE | PREMIUM NATURAL COSMETICS INC | 163f32cd-4e51-950a-e063-6394a90a4816 | 2025-10-17 | Warnings | M013 |
| Menstrual Complete Maximum Strength | ACETAMINOPHEN, CAFFEINE, PYRILAMINE MALEATE | CHAIN DRUG MARKETING ASSOCIATION INC | 913d8bdb-7644-464c-b9a6-55387ff12059 | 2025-10-17 | Warnings | M013 |
| Alka-Seltzer Hangover Relief | ANHYDROUS CITRIC ACID, ASPIRIN, AND SODIUM BICARBONATE | Bayer HealthCare LLC. | dc235b06-999e-221d-e053-2a95a90a0ce1 | 2025-10-16 | Warnings | M013 |
| Aspirin 81mg | ASPIRIN ENTERIC COATED TABLETS 81MG | VITANE PHARMACEUTICALS, INC | 41386de5-5857-efab-e063-6294a90afd9c | 2025-10-15 | Warnings | M013 |
| Aspirin 81mg | ASPIRIN ENTERIC COATED TABLETS 81MG | VITANE PHARMACEUTICALS, INC | 4138d4c0-baa5-1f20-e063-6394a90a788f | 2025-10-15 | Warnings | M013 |
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 198440 | acetaminophen 500 MG Oral Tablet | PSN | fc2d4367-8884-4b76-aa3e-8c35be1ace49 | 6 |
| 198440 | acetaminophen 500 MG Oral Tablet | SCD | fc2d4367-8884-4b76-aa3e-8c35be1ace49 | 6 |
| 198440 | APAP 500 MG Oral Tablet | SY | fc2d4367-8884-4b76-aa3e-8c35be1ace49 | 6 |
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|---|
| 69842-484-47 | 69842048447 | 1 BOTTLE in 1 CARTON (69842-484-47) > 150 TABLET in 1 BOTTLE | 1 bottle | 2018-06-12 | 0000-00-00 | No | No | Current |
| 69842-484-62 | 69842048462 | 1 BOTTLE in 1 CARTON (69842-484-62) / 24 TABLET in 1 BOTTLE | 1 bottle | 2018-06-12 | 0000-00-00 | No | No | Current |
| 69842-484-71 | 69842048471 | 1 BOTTLE in 1 CARTON (69842-484-71) / 50 TABLET in 1 BOTTLE | 1 bottle | 2018-06-12 | 0000-00-00 | No | No | Current |
| 69842-484-78 | 69842048478 | 1 BOTTLE in 1 CARTON (69842-484-78) / 100 TABLET in 1 BOTTLE | 1 bottle | 2018-06-12 | 0000-00-00 | No | No | Current |
| 69842-484-83 | 69842048483 | 1 BOTTLE in 1 CARTON (69842-484-83) / 225 TABLET in 1 BOTTLE | 1 bottle | 2018-06-12 | 0000-00-00 | No | No | Current |
| 69842-484-87 | 69842048487 | 2 BOTTLE in 1 CARTON (69842-484-87) > 150 TABLET in 1 BOTTLE | 2 bottle | 2018-06-12 | 0000-00-00 | No | No | Current |
| 69842-484-90 | 69842048490 | 500 TABLET in 1 BOTTLE (69842-484-90) | 500 tablet | 2018-06-12 | 0000-00-00 | No | No | Current |
| 69842-484-93 | 69842048493 | 1000 TABLET in 1 BOTTLE (69842-484-93) | 1000 tablet | 2018-06-12 | 0000-00-00 | No | No | Current |